To all Longs, I think there are several approac
Post# of 208
(Total Views: 411)
Posted On: 08/17/2020 12:06:38 AM
To all Longs,
I think there are several approaches to COVID-19 underway and all of them are happening at the same time. One approach is to have vaccine going and of course that is complicated approach as vaccines take time to make and vaccine may elicit immunity in the body but also can make one feel more sick instead of preventing one from geting sick when exposed to COVID-19.
So a lot of work on research & safety has to be done. On the other side though there is also plethora of therapeutic drugs in development that offer as treatments to prevent the front line workmen from getting severely ill. Then there are questions are if one gets severely sick what treatments can be used to prevent you from dying.
TSOI has quickly re-positioned its 3 years of R&D to offer Neutraceuticals, Cellular Therapy approcches to treat the severe end of COVID-19 spectrum . How does COVID-19 kill you? Basically one gets drowned within the lungs. One's lungs get flooded with fluid which is called ARDS. How TSOI treats the ARDS without limiting the body's ability to clear the VIRUS .... thats a tricky question it turns out that our own stem cells may possess the ability to tone down that inflammation to reduce swelling of fluids in the lungs without inhibiting the bodys ability to clear the VIRUS.
Now as we wait for the PHASE II clinical trial of QUADRAMUNE already underway to be concluded in November 2020 timeframe. As we all know TSOI is still treating and enrolling patients who are severely sick in many hospitals all over USA and the name of the game is whether TSOI can prevent these patients from dying with suffering from late stage end symptons of COVID-19.
One other COVID-19 treatment approach that TSOI uses is supercharged DENDRITIC CELLS called STEMVACS ..TSOI has adopted this novel approach with allogeneic DENDRITIC cells which are like pills in a bottle and they are off-the-shelf and has tremendous potential to reach its target. Beyond COVID-19, TSOI is working on similar approaches to treat cancer, RA, Diabetes II and CTE/TBI and Mental Depression, Suicide.
So TSOI is exciting micro cap innovative biotech company is in good R&D position wise and ready to unleash innovative therapeutic products to treat COVID-19, SARS, ARDS.
In terms of other categories of treatment of COVID-19 other than vaccine, is a treatment like antidote called MAB (monoclonal Anti Bodies) i.e before one gets sick and that monoclonal Anti Body looks like can prevent the virus from getting you sick. Also several BIG pharma companies are also working on coming up with their own version of MABs. TSOI produces MABs which are highly efficacious and have the keys to bind with the immune system but also can be made in HUGE mass production to be able to have millions in numbers to tackle the fall/winter flu season that can hit US with more COVID-19 infection waves
I think there are several approaches to COVID-19 underway and all of them are happening at the same time. One approach is to have vaccine going and of course that is complicated approach as vaccines take time to make and vaccine may elicit immunity in the body but also can make one feel more sick instead of preventing one from geting sick when exposed to COVID-19.
So a lot of work on research & safety has to be done. On the other side though there is also plethora of therapeutic drugs in development that offer as treatments to prevent the front line workmen from getting severely ill. Then there are questions are if one gets severely sick what treatments can be used to prevent you from dying.
TSOI has quickly re-positioned its 3 years of R&D to offer Neutraceuticals, Cellular Therapy approcches to treat the severe end of COVID-19 spectrum . How does COVID-19 kill you? Basically one gets drowned within the lungs. One's lungs get flooded with fluid which is called ARDS. How TSOI treats the ARDS without limiting the body's ability to clear the VIRUS .... thats a tricky question it turns out that our own stem cells may possess the ability to tone down that inflammation to reduce swelling of fluids in the lungs without inhibiting the bodys ability to clear the VIRUS.
Now as we wait for the PHASE II clinical trial of QUADRAMUNE already underway to be concluded in November 2020 timeframe. As we all know TSOI is still treating and enrolling patients who are severely sick in many hospitals all over USA and the name of the game is whether TSOI can prevent these patients from dying with suffering from late stage end symptons of COVID-19.
One other COVID-19 treatment approach that TSOI uses is supercharged DENDRITIC CELLS called STEMVACS ..TSOI has adopted this novel approach with allogeneic DENDRITIC cells which are like pills in a bottle and they are off-the-shelf and has tremendous potential to reach its target. Beyond COVID-19, TSOI is working on similar approaches to treat cancer, RA, Diabetes II and CTE/TBI and Mental Depression, Suicide.
So TSOI is exciting micro cap innovative biotech company is in good R&D position wise and ready to unleash innovative therapeutic products to treat COVID-19, SARS, ARDS.
In terms of other categories of treatment of COVID-19 other than vaccine, is a treatment like antidote called MAB (monoclonal Anti Bodies) i.e before one gets sick and that monoclonal Anti Body looks like can prevent the virus from getting you sick. Also several BIG pharma companies are also working on coming up with their own version of MABs. TSOI produces MABs which are highly efficacious and have the keys to bind with the immune system but also can be made in HUGE mass production to be able to have millions in numbers to tackle the fall/winter flu season that can hit US with more COVID-19 infection waves
(0)
(0)